Sorry, you need to enable JavaScript to visit this website.

Pfizer Announces New Chief Medical Officer

Pfizer Inc. (NYSE: PFE) Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice President. In this role, Dr. Cavazzoni will lead Pfizer’s regulatory, pharmacovigilance, safety, epidemiology, and medical information and evidence generation, among other medical functions, and will report to Chris Boshoff, M.D., Ph.D., Chief Scientific Officer and President, Pfizer Research & Development. Dr. Cavazzoni will succeed Aida Habtezion, M.D., MSc, FRCPC, AGAF who will be leaving Pfizer to pursue other opportunities.

Pfizer Announces New Chief Oncology Officer

New York, February 5, 2025 Pfizer Inc. (NYSE: PFE) today announced that Jeffrey Legos, PhD, MBA, will join the company as Chief Oncology Officer. In this role, Dr. Legos will be responsible for leading the company’s Oncology Research & Development, overseeing all functions from pre-clinical to late-stage clinical development activities. Dr. Legos will report to Chris Boshoff, M.D., PhD, Chief Scientific Officer and President, Pfizer Research & Development, and will represent Oncology on Pfizer’s R&D Leadership Team. Dr.

Subscribe to Updates